Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

AMGN

Amgen (AMGN)

Amgen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:BIT:AMGN
DateTimeSourceHeadlineSymbolCompany
10/19/20092:57PMDow Jones News2nd UPDATE: FDA Delays Decision On Amgen Bone DrugNASDAQ:AMGNAmgen Inc.
10/19/200911:17AMDow Jones NewsUPDATE: FDA Delays Decision On Amgen Bone Drug For Added InfoNASDAQ:AMGNAmgen Inc.
10/19/20099:55AMDow Jones NewsFDA Seeks Added Info On Amgen Bone Drug, Delays DecisionNASDAQ:AMGNAmgen Inc.
10/16/20092:55PMDow Jones NewsUS EQUITIES WEEK AHEAD: More 3Q Results; Windows 7 LaunchesNASDAQ:AMGNAmgen Inc.
10/14/20092:44PMDow Jones NewsAmgen's Bone Drug May Face Delays In FDA DecisionNASDAQ:AMGNAmgen Inc.
10/12/200910:57AMDow Jones NewsDrug Stocks Edge Higher; DepoMed SinksNASDAQ:AMGNAmgen Inc.
10/01/20091:22PMDow Jones NewsHospira Learning Valuable Lessons In European Biosimilar MarketNASDAQ:AMGNAmgen Inc.
09/23/200910:22AMDow Jones NewsConflicting Erbitux Study Data Hurts Merck SharesNASDAQ:AMGNAmgen Inc.
09/23/20095:59AMDow Jones NewsMerck Shares Rise On Positive Erbitux Data For Colon CancerNASDAQ:AMGNAmgen Inc.
09/22/20097:28AMDow Jones NewsAmgen's Denosumab Aids Bones In Breast-Cancer PatientsNASDAQ:AMGNAmgen Inc.
09/17/20094:04PMDow Jones NewsAmgen Hiring Mobile Reps In Building Bone Drug Sales ForceNASDAQ:AMGNAmgen Inc.
09/17/20099:31AMDow Jones NewsMerck KGaA's Erbitux Data May Be Upstaged By Rival VectibixNASDAQ:AMGNAmgen Inc.
09/15/20095:52PMDow Jones News2nd UPDATE: US Court Won't Disturb Injunction Against Roche Anemia DrugNASDAQ:AMGNAmgen Inc.
09/15/20095:39PMDow Jones NewsUPDATE: US Court Won't Disturb Injunction Against Roche Anemia DrugNASDAQ:AMGNAmgen Inc.
09/15/200912:22PMDow Jones NewsUS Court Won't Disturb Injunction Against Roche Anemia DrugNASDAQ:AMGNAmgen Inc.
08/25/20095:46PMDow Jones NewsAmgen: Aranesp Doesn't Show Significant Bad Effects In StudyNASDAQ:AMGNAmgen Inc.
08/17/20099:40AMDow Jones NewsEuropean Biosimilars Market May Hint At Limited US ThreatNASDAQ:AMGNAmgen Inc.
08/14/200911:29AMDow Jones NewsSUBSCRIBERS: FDA OKs Saphris News Already ReportedNASDAQ:AMGNAmgen Inc.
08/13/20097:34PMDow Jones News5th UPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
08/13/20096:51PMDow Jones News4th UPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
08/13/20096:03PMDow Jones News3rd UPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
08/13/20095:13PMDow Jones News2nd UPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
08/13/20094:10PMDow Jones NewsUPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
08/13/20093:38PMDow Jones NewsFDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
08/11/200912:56PMDow Jones NewsFDA: Amgen Osteoporosis Drug Could Affect Immune SystemNASDAQ:AMGNAmgen Inc.
08/07/20091:01PMDow Jones NewsAmgen's Cancer News Promising, But Bone Drug Still The FocusNASDAQ:AMGNAmgen Inc.
08/04/20093:43PMDow Jones NewsUPDATE: FDA: Requires Stronger Warnings For TNF Blocker DrugsNASDAQ:AMGNAmgen Inc.
08/04/20092:05PMDow Jones NewsFDA: Requires Stronger Class Warnings For TNF Blocker DrugsNASDAQ:AMGNAmgen Inc.
08/04/200912:13PMDow Jones NewsAmgen's Positive Bone Drug Data Missed Some High ExpectationsNASDAQ:AMGNAmgen Inc.
08/03/20096:01PMDow Jones NewsAmgen Bone Drug Shows Promise In Phase 3 TrialNASDAQ:AMGNAmgen Inc.
 Showing the most relevant articles for your search:BIT:AMGN